PayerTalkCE® Presents: Navigating the Complexities of Hypertrophic Cardiomyopathy

This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/hypertrophic-cardiomyopathy-payertalkce/. Through a multidisciplinary discussion format, the podcast will address critical gaps in payer understanding of hypertrophic cardiomyopathy (HCM), including guideline interpretation, coverage implications, emerging pharmacologic options such as cardiac myosin inhibitors, and the importance of shared decision‑making to support individualized, high‑quality care. Using real‑world HCM case scenarios, the faculty will explore strategies to optimize benefit design, prior authorization, and access pathways to improve clinical and economic outcomes across health systems. Learners will receive targeted, practical insights that can help payers implement evidence‑based policies that enhance appropriate, timely treatment for patients with HCM.